Stage 4 squamous cell carcinoma of the tongue in a child: Complete response to chemoradiotherapy

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 9, 2001, Pages 612-615

  Soni, Sandeep ^a   Radel, Eva ^a   Smith, Richard V ^a   Edelman, Morris ^a   Sattenberg, Ron ^a   Wadler, Scott ^a   Beitler, Jonathan J ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Chemoradiotherapy; Chemotherapy; Hydroxyurea; Hyperfractionated external radiation therapy; Pediatric squamous cell carcinoma; Radiotherapy; Tongue

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROXYUREA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; HYDROXYUREA; NASOPHARYNX; NEOPLASM INVASIVENESS; REMISSION INDUCTION; SUBMANDIBULAR GLAND; TONGUE NEOPLASMS; TONSIL;

EID: 0035690975     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200112000-00012     Document Type: Article

References (21)

1. Amichetti M. Squamous cell carcinoma of the oral tongue in patients less than fifteen years of age. J Cranio Max Fac Surg 1989; 17: 75-7.
2. Son YH, Knapp DS. Oral cavity and oropharyngeal cancer in a younger population. Cancer 1985; 55: 441-4.
3. Jones JB, Lampe HG, Cheung HW. Carcinoma of the tongue in young patients. J Otolaryngol 1989; 18: 105-8.
4. Usenius T, Karja J, Collan Y. Squamous cell carcinoma of the tongue in children. Cancer 1987; 60: 236-9.
5. Harari PM. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? J Clin Oncol 1997; 15: 2050-5.
6. Munro AJ. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71: 83-91.
7. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. Meta-analysis of prospective and randomized trials. J Clin Oncol 1996; 14: 838-47.
8. Cancer staging of lip and oral cavity. In: Fleming ID, Cooper JS, et al., eds. AJCC Cancer Staging Manual, Philadelphia: Lippincott-Raven, 1997: 24-7.
9. Beitler JJ, Smith RV, Haynes H, et al. A phase I trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck. Invest New Drugs 1998; 16: 161-9.
10. Grobb JJ, Breton A, Bonafe JL, et al. Keratitis, ichthyosis and deafness (KID) syndrome. Arch Dermatol 1987; 123: 777-82.
11. Kaplan MJ, Sabio H, Wanebo HJ, et al. Squamous cell carcinoma in the immunosuppressed patient: Fanconi’s anemia. Laryngoscope 1985; 95: 771-4.
12. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Arch Dermatol 1987; 123: 341-50.
13. Nuutinen J, Karja J, Sainio P. Epithelial second malignant tumors in retinoblastoma survivors. Acta Opthalmol 1982; 60: 133-40.
14. Morehead JM, Parsons DS, McMahon DP. Squamous cell carcinoma of the tongue occurring as a subsequent malignancy in a 12-year-old acute leukemia survivor. Int J Pediatr Otorhinolaryngol 1993; 26: 89-94.
15. Franceschi D, Gupta R, Spiro RH, et al. Improved survival in the treatment of squamous cell carcinoma of the oral tongue. Am J Surg 1993; 166: 360-5.
16. Sarkaria JN, Harari PM. Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck 1994; 16: 107-11.
17. Fazekas JT, Sommer C, Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cell cancers of the oral cavity, oropharynx, supraglottic larynx and hypopharynx. Concluding report of an RTOG randomized trial on 638 patients. Int J Radiat Oncol Biol Phys 1980; 6: 533-41.
18. Jeremie B, Shibamoto Y, Stanisavljevic B, et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol 1991; 43: 29-37.
19. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiotherapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91: 2081-6.
20. Wadler S, Horowitz R, Rao J, et al. Interferon augments the cytotoxicity of hydroxyurea without enhancing its activity against the M2 subunit of ribonucleotide reductase: effects in wild-type and resistant human colon cancer cells. Cancer Chemother Pharmacol 1996; 38: 522-8.
21. Smith RV, Kotz T, Beitler JJ, et al. Long-term swallowing problems following organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg 2000; 126: 384-9.